Navigation Links
Biotherm Announces a Unique Dermobiotic Three-Step Anti-Cellulite Slimming Treatment
Date:4/18/2008

NEW YORK, April 18 /PRNewswire/ -- Armed with over 30 years of experience in slimming products, Biotherm biologists have made a new discovery set to revolutionize cosmetic treatments for stubborn cellulite. This spring, Biotherm launches CELLULI LASER(TM), a unique three-step system consisting of a scrub, massage tool and treatment gel providing visible, 10 day results in 71% of the women tested**.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080418/AQF014)

Inspired by the astounding results laser techniques produce on the skin, Biotherm's new CELLULI LASER treatment gel contains BIOFIBRINE(TM), an exclusive Biotherm technology that targets fibers to help stimulate production of collagen*.

"The idea underlying the BIOFIBRINE(TM) complex was inspired by the way lasers work," explains Dr. Blanchemaison, a specialist in vascular medicine and Director of Studies at the University of Paris V Medical School. Dr. Blanchemaison is also the author of Conquering Cellulite.

Biotherm biologists have discovered that when collagen fibers are flexible, the appearance of cellulite is reduced. The BIOFIBRINE complex is a combination of Carbocysteine and Biopeptides. Carobcystiene has anti-glycation properties that help collagen fiber from becoming hard. The biopeptides help stimulate new collagen production*. Other ingredients such as caffeine, ginkgo, ginseng, and cola nut -- all found in the new CELLULI LASER products -- also help to contribute to the reduction of the appearance of cellulite.

How do the treatments work?

The warming and exfoliating texture of CELLULI LASER SCRUB targets unattractive "orange peel" bumps and bulges that sometimes appear on the legs, stomach and arms. Designed for application on dry skin, the texture is suggested as the first step of the treatment. Next, by facilitating a professional style kneading massage from the comfort
'/>"/>

SOURCE Biotherm
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Osteotech Announces First Quarter Earnings Release and Conference Call Schedule
2. ARUP Laboratories CEO and Co-Founder Announces Retirement
3. Gene Network Sciences Names New CSO and Announces New Scientific Advisory Board
4. Victhom announces promising results on the proof of concept for its unique closed-loop neuromodulation system
5. Oncolytics Biotech Inc. Announces Gene Therapy Publication on Reovirus Treatment for Melanoma
6. EMD Serono Announces Planned Investment of $50 Million in Research Center in Massachusetts
7. Angiotech announces director resignation
8. BioHorizons Announces the Purchase of Implant Logic Systems
9. CV Therapeutics Announces $185 Million Transaction with TPG-Axon Capital for Half of Royalty for Lexiscan(TM) (regadenoson) Injection
10. Arpida Announces Conference Call on 17 April
11. Arpida Announces Agenda Items for Shareholders Meeting

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...and, November 24 deCODE,... approval of all of its,"first day" motions by the...e,(the "Bankruptcy Court"). deCODE last week filed...of the United States Bankruptcy Code with the,Bank...Bankruptcy Court allow the company to continue,to ...
(Date:11/24/2009)... Blue Marble Energy Corp. announced today that the...ty (OPDA) were recently awarded $2 million by Wash...oard (CERB) in a private/public partnership to con...refinery in Lincoln County, WA. ,, "This inve... our biorefinery and bring over 70 green jobs to L...
(Date:11/24/2009)...wire-FirstCall/ -- Shire plc (LSE: SHP,NASDAQ: S...pany, today,announced that it has submitted a MAA ... alfa, the company,s enzyme replacement therapy in...isease. This is the third marketing,application fo... previous,submissions in the United States and Can...
(Date:11/24/2009)...ustomers with Partners Validated to Process and An... , Ottawa, ON (PRWEB) Nove... of products for biological sample collection, sta...w global partner program. The program offers signi...unity and is designed to help partners scale and d...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 4DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3
... Corporation,today announced its V-Link Luer-activ...ing, the first needleless intravenous (IV) connect...ilable for hospitals in the,United States and Cana... on,average 99.9 percent or more of specific commo...use catheter-related bloodstream,infections. Patho...
...scussed during Omnicell,educational, programs Apr...nd April,22 at, The Mid-America Club in Chicago, ..., Omnicell, Inc. (Nasdaq: OMCL ), a leading provi...nd operational efficiency in,healthcare facilities...uccessful implementation of SinglePointe(TM), a to...
...., Ph.D. a,physician-geneticist and leader of the ...the inaugural Inamori Ethics Prize from the Inamor...t Case Western Reserve,University., (Photo: http..., The Inamori Ethics Prize honors outstanding int...ly to an individual who has demonstrated,exemplary...
Other Biology Technology:Baxter's V-Link Luer-Activated Device With VitalShield Protective Coating Now Available For Hospitals 2Baxter's V-Link Luer-Activated Device With VitalShield Protective Coating Now Available For Hospitals 3Baxter's V-Link Luer-Activated Device With VitalShield Protective Coating Now Available For Hospitals 4Rice Memorial Hospital Implements SinglePointe(TM) Automated Patient-Specific Management Solution From Omnicell 2Rice Memorial Hospital Implements SinglePointe(TM) Automated Patient-Specific Management Solution From Omnicell 3Leading Geneticist Francis Collins Named First Recipient of the Inamori Ethics Prize at Case Western Reserve University 2Leading Geneticist Francis Collins Named First Recipient of the Inamori Ethics Prize at Case Western Reserve University 3Leading Geneticist Francis Collins Named First Recipient of the Inamori Ethics Prize at Case Western Reserve University 4
(Date:11/24/2009)...Scientists have crystallised a protein that may he.... The protein could be used by probiotic producers... benefit to people. , "Probiotics need to interac...ffect, and if they attach to surfaces in the gut t... exert their activity," says Dr Nathalie Juge from...
(Date:11/24/2009)... BATON ROUGE Antarctica has long held secrets of... until recently, there has been very little inform...neath miles of ice for millions of years. Now, a t...ng LSU have been funded to the tune of $10 millio...SF, to get to the bottom of things literally. The...
(Date:11/23/2009)...Washington, D.C. The community-associated strain ...cteria resistant to most common antibioticsposes a...nd is making its way into hospitals, according to ...ous Diseases . , The new threat is easily picke... places and has increased the overall burden of MR...
Breaking Biology News(10 mins):A sticky solution for identifying effective probiotics 2LSU gets to the bottom of things -- in Antarctica 2New study finds MRSA on the rise in hospital outpatients 2The Maurer Foundation for Breast Health Education Launches Integrated Rebranding Operation 52200 1The Maurer Foundation for Breast Health Education Launches Integrated Rebranding Operation 52200 2Swissmedic Grants Debiopharm Marketing Authorisation for Moapar 28R 29 a New Therapeutic Avenue for the Treatment of Sexual Deviations 4759 1Swissmedic Grants Debiopharm Marketing Authorisation for Moapar 28R 29 a New Therapeutic Avenue for the Treatment of Sexual Deviations 4759 2Swissmedic Grants Debiopharm Marketing Authorisation for Moapar 28R 29 a New Therapeutic Avenue for the Treatment of Sexual Deviations 4759 3JACQUES Initiative Joins Maryland AIDS Administration to Extend HIV Testing to the Faith Based Community 52195 1JACQUES Initiative Joins Maryland AIDS Administration to Extend HIV Testing to the Faith Based Community 52195 2JACQUES Initiative Joins Maryland AIDS Administration to Extend HIV Testing to the Faith Based Community 52195 3JACQUES Initiative Joins Maryland AIDS Administration to Extend HIV Testing to the Faith Based Community 52195 4
...by Stephen Dalton, professor and Georgia Research ...he University of Georgia, has been awarded $9.2 mi... National Institute of General Medical Sciences, p...n,s group, headquartered in the department of bioc...olecular underpinnings of the early steps that ste...
...has waged a successful guerrilla war against the h...eek,s Journal of Biological Chemistry has expose...immune proteins, which may aid in future drug deve...mitted to people via infected mosquitoes. Once ins...hop in liver cells, then move into red blood cells...
...cting vast amounts of diverse genomic data with ev...ze these data in an integrated manner have lagged ...is growing need, researchers at the Broad Institut...IGV), a novel and freely available visualization t...analyze different types of genomic data, and gives...
Other Biology News:UGA researchers win $9.2 million stem cell grant from NIH 2Research exposes new target for malaria drugs 2Broad Institute researchers introduce next generation tool for visualizing genomic data 2
Mouse Anti-Human HLA II DG+DR+DP Monoclonal Antibody, Unconjugated, Clone IQU9 from Diaclone
Duck Anti-Phenytoin-BSA Antibody, Unconjugated from Good Biotech Corp
Anti-Tropomyosin 4 Antibody, Unconjugated from CHEMICON
Mouse Anti-Cytokeratin 8 + 18 + 19 Monoclonal Antibody, Unconjugated, Clone 2A4 from Abcam
Biology Products: